Neuropace (NPCE)Orbimed Advisors LLC reduced its stake -310K shares

2.1M

Shares reported · -310K vs prior quarter

0.56%

Disclosed portfolio weight

$27.6M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 5, 2026Federal contract · $48K obligatedDepartment of Veterans Affairs awarded NeuroPace Inc: $48K obligated to date
2. Mar 31, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Jun 4, 2026Federal contract · $48K obligatedDepartment of Veterans Affairs awarded NeuroPace Inc: $48K obligated to date
2. Aug 11, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Neuropace

For Neuropace, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NPCE page.

How this filing works

• SEC Form 13F

Other disclosures at Neuropace

• USAspending.gov award recordOct 5, 2026
• SEC Form 13F-HRAug 14, 2026
• USAspending.gov award recordJun 9, 2026
• USAspending.gov award recordMar 17, 2026
• USAspending.gov award recordMar 11, 2026
• SEC Form 13F-HRFeb 17, 2026

Everything OQRO holds on this company is on its NPCE page.